Ligand Pharmaceuticals Incorporated LGNZZ
0.07 USD 0.00 (+0.00%)
As ofOct 19, 2026, 11:04 AM EDT
0.065 Day range 0.065
0.065 52-week range 0.17
- YTD
- 0.00%
- 1 year
- 0.00%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
0.59 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 0.0×
P/S 0.0×
P/B 0.0×
P/FCF 0.0×
EV/EBITDA -1.4×
EV/Sales -1.0×
FCF Yield 3327.7%
Profitability
Gross Margin 82.4%
Operating Margin 17.6%
Net Margin 46.4%
ROE 12.2%
ROIC 2.4%
ROA 8.0%
Growth (YoY)
Revenue 60.4%
Operating Income 105.0%
EPS (diluted) 1126.0%
Free Cash Flow -48.6%
Financial Health
Current Ratio 22.2×
Quick Ratio 22.0×
Debt / Equity 0.4×
Net Debt / EBITDA -1.4×
Interest Coverage 10.0×
Dividends
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31
